Fibromun, Dacarbazine medac 1000 mg, powder for solution for infusion
PH-L19TNFSARC-03/18
Phase 2 small_molecule active
Quick answer
Fibromun, Dacarbazine medac 1000 mg, powder for solution for infusion for Unresectable and/or metastatic soft-tissue sarcoma after failure of at least two prior systemic therapy regimens. is a Phase 2 program (small_molecule) at Philogen S.p.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Philogen S.p.A.
- Indication
- Unresectable and/or metastatic soft-tissue sarcoma after failure of at least two prior systemic therapy regimens.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active